NCT06265948

Brief Summary

( post operative pain between intravenous infusion ketofol and standard inhalational general anesthesia in abdominal cancer surgeries )

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 20, 2024

Completed
10 days until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2024

Enrollment Period

1 year

First QC Date

February 11, 2024

Last Update Submit

February 11, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • post operative pain

    pain according to VAS score

    two hours

Study Arms (1)

The sample will be randomly assigned into one of two equal groups ((Group-I (n

Sample size calculation was carried out using G\*Power 3 software (Faul et al., 2007)1 calculated minimum sample of 80 patient candidate for cancer surgery will be needed. The sample will be randomly assigned into one of two equal groups ((Group-I (n=40): will receive standard general anesthesia as control, and Group III (n=40): will receive Ketofol in addition to the standard general anesthesia. The calculated sample will be needed to detect an effect size of 0.1 in the RM-ANOVA (within group-between groups and interaction) on repeated measurements (every 2-hours postoperatively) for the mean VAS score, with an error probability of 0.05 and 95% power.

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Inclusion Criteria: * a. Inclusion criteria: 1. Age group 18 - 60 years old. 2. Both gender 3. ASA 1and 2 Exclusion Criteria: * a. Inclusion criteria: 1. Age group 18 - 60 years old. 2. Both gender 3. ASA 1and 2 b. Exclusion criteria: <!-- --> 1. Patient refusal, 2. History of cardiac or respiratory disease, psychological disorders, 3. High risk of regurgitation or aspiration based on a history of diabetes, hiatus hernia, gastroesophageal reflux, and obesity, 4. neck pathology, 5. Predicted difficult airway (history of difficult airway, mouth opening

You may qualify if:

  • Age group 18 - 60 years old.
  • Both gender
  • ASA 1and 2

You may not qualify if:

  • Age group 18 - 60 years old.
  • Both gender
  • <!-- -->
  • Patient refusal,
  • History of cardiac or respiratory disease, psychological disorders,
  • High risk of regurgitation or aspiration based on a history of diabetes,
  • hiatus hernia, gastroesophageal reflux, and obesity,
  • neck pathology,
  • Predicted difficult airway (history of difficult airway, mouth opening

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

February 11, 2024

First Posted

February 20, 2024

Study Start

March 1, 2024

Primary Completion

March 1, 2025

Study Completion

May 1, 2025

Last Updated

February 20, 2024

Record last verified: 2024-02